Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Current Opinion in Molecular Therapeutics|April 8, 2010
Glembatumumab vedotin, a conjugate of an anti-glycoprotein non-metastatic melanoma protein B mAb and monomethyl auristatin E for the treatment of melanoma and breast cancerLouie Naumovski, Jagath R Junutula
Current Drug Delivery|November 2, 2010
Emerging role of immunoPET in receptor targeted cancer therapyJan Marik, Jagath R Junutula
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2013
Engineering THIOMABs for site-specific conjugation of thiol-reactive linkersSunil Bhakta, Helga Raab, Jagath R Junutula
Methods in Enzymology|February 14, 2006
Class I FIPs, Rab11-binding proteins that regulate endocytic sorting and recyclingElizabeth Tarbutton, Andrew A Peden, Jagath R Junutula, et al.
Mabs|August 28, 2023
Exploration of the antibody-drug conjugate clinical landscapeHeather Maecker, Vidya Jonnalagadda, Sunil Bhakta, et al.
Mabs|January 16, 2014
Site-specific antibody drug conjugates for cancer therapySiler Panowski, Sunil Bhakta, Helga Raab, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Exatecan Payload-Based Antibody-Drug Conjugates with a Short Hydrophilic Cleavable LinkerVasu Jammalamadaka, Jiang Liu, Sunil Bhakta, et al.
Molecular Biology of the Cell|June 8, 2004
The RCP-Rab11 complex regulates endocytic protein sortingAndrew A Peden, Eric Schonteich, John Chun, et al.
The Journal of Biological Chemistry|June 3, 2004
Molecular characterization of Rab11 interactions with members of the family of Rab11-interacting proteinsJagath R Junutula, Eric Schonteich, Gayle M Wilson, et al.
The EMBO Journal|November 4, 2006
Rab14 is critical for maintenance of Mycobacterium tuberculosis phagosome maturation arrestGeorge B Kyei, Isabelle Vergne, Jennifer Chua, et al.
Pageof 5